FDA Approved: ISTURISA — Supplemental Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Isturisa (osilodostat) submitted by Recordati Rare Diseases, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease
• Cushing Syndrome

Drugs mentioned

• Isturisa (osilodrostat)

Snippet

SUPPL AP for ISTURISA (OSILODROSTAT)